Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $33.00 Consensus Target Price from Analysts
Shares of Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month target […]
Shares of Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month target […]
